All News #Library
Biotech
Zetagen Therapeutics Completes Oversubscribed Series B1 Round
25 Nov 2025 //
BUSINESSWIRE
Zetagen to Present Promising Preclinical Data at SABCS
04 Nov 2025 //
BUSINESSWIRE
Zetagen Therapeutics To Unveil Phase 2 Trial Results
04 Nov 2025 //
BUSINESSWIRE

Market Place
Sourcing Support